ArticleApplied psychophysiology and biofeedback2026
A Smart HRV-Guided Respiratory Biofeedback System for Combined Respiratory and Psychological Recovery During COVID-19 Oxygen Weaning.
Article in Applied psychophysiology and biofeedback, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has placed substantial pressure on intensive care units (ICUs), particularly in managing patients who require oxygen therapy and must be safely weaned from it. This study evaluated an HRV-guided respiratory biofeedback program as a non-pharmacological method to reduce respiratory discomfort and psychological distress during oxygen weaning in COVID-19 patients. A non-randomized quasi-experimental study was conducted with 80 ICU patients at Albehera Hospital, Beheira, Egypt. Patients were allocated to either a biofeedback group ([Formula: see text]) or a control group ([Formula: see text]). Both groups received standard oxygen-weaning care and routine nursing support, but only the biofeedback group received structured sessions combining diaphragmatic breathing with heart rate variability based respiratory training. The Respiratory Distress Observation Scale (RDOS) and the Depression Anxiety Stress Scale (DASS-21) were administered before and after the intervention. After adjusting for baseline scores, the biofeedback group demonstrated a markedly larger reduction in RDOS scores (from 14.48 to 4.23; [Formula: see text]) and significant improvements in DASS-21 depression, anxiety, and stress subscales ([Formula: see text]), whereas the control group showed only minimal changes. These findings suggest that HRV-guided respiratory biofeedback may enhance both respiratory comfort and psychological well-being during oxygen weaning in COVID-19 patients and could serve as a valuable adjunct to standard ICU care. Further randomized controlled trials are warranted to confirm these results and guide clinical implementation.
Indexed as
Identifiers
41838315What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.